XLO - Xilio Therapeutics, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
1/3/25 16:15	1/1/25	XLO	Health	Drug	Pharmaceutical Preparations	Luptakova Katarina	MA	O	CHIEF ME	M.d	0	0.00	17	New	17	D
1/3/25 16:15	1/1/25	XLO	Health	Drug	Pharmaceutical Preparations	Frankenfield Christopher James	MA	O	CFO	M.d	0	0.00	19		12	D
1/3/25 16:15	1/2/25	XLO	Health	Drug	Pharmaceutical Preparations	Frankenfield Christopher James	MA	O	CFO	S.d	-7	0.9837	-7	-36	12	D
1/3/25 16:15	1/1/25	XLO	Health	Drug	Pharmaceutical Preparations	Brennan Kevin M.	MA	O	SVP,FINA	M.d	0	0.00	5		3	D
1/3/25 16:15	1/2/25	XLO	Health	Drug	Pharmaceutical Preparations	Brennan Kevin M.	MA	O	SVP,FINA	S.d	-2	0.9837	-2	-36	3	D
1/3/25 16:15	1/1/25	XLO	Health	Drug	Pharmaceutical Preparations	Russo Rene	MA	DO	P,CEO	M.d	0	0.00	44	22	245	D
12/19/24 16:19	12/18/24	XLO	Health	BioPrd	Biological Products, (No Diag	Gilead Sciences, Inc.	CA	T		P.d	1,830	1.04	1,760	24	9,105	D
4/3/24 18:50	4/2/24	XLO	Health	BioPrd	Biological Products, (No Diag	Gilead Sciences, Inc.	CA	T		P.d	369	0.7600	485	7	7,345	D
2/9/24 16:33	2/8/24	XLO	Health	Drug	Pharmaceutical Preparations	Atlas Venture Fund Xi, L.P.	MA	T		S	-1	0.6400	-1	0	2,754	M
1/16/24 18:16	1/11/24	XLO	Health	Drug	Pharmaceutical Preparations	Atlas Venture Fund Xi, L.P.	MA	T		S.m	-4	0.8502	-4	0	2,755	M

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person